There were 1,332 press releases posted in the last 24 hours and 399,889 in the last 365 days.

CMV Might Cause Blood Clots; The CBCD Reviews the Medical Evidence

In recent years, CMV infection has been linked to the development of venous thrombosis. (1)

The CMV causes changes in the regular function of blood vessels, which in turn causes an increase in blood clotting factors.
— Dr. Galli
ROCHESTER, NEW YORK, UNITED STATES OF AMERICA, September 24, 2015 /EINPresswire.com/ --

“Infected with the cytomegalovirus (CMV)? The CBCD recommends Gene-Eden-VIR or Novirin.” – Greg Bennett, CBCD

A study showed that there is a clear link between the presence of the human cytomegalovirus (CMV), a human herpes virus, and the development of a condition called deep vein thrombosis (DVT). (1) According to Dr. Galli and colleagues, the CMV “seems to directly interfere with the hemostatic system. The activation of CMV-infected endothelial cells induces membrane perturbation and expression of adhesion molecules that, consequently, enhance platelet and leukocyte adhesion.” (1) Dr. Galli is from the University of Insubria, Varese, in Italy.

In other words, what Dr. Galli is saying, is that the CMV causes changes in the regular function of blood vessels, which in turn causes an increase in blood clotting factors. This can cause deep vein thrombosis, which “occurs when a blood clot (thrombus) forms in one or more of the deep veins in your body, usually in your legs. Deep vein thrombosis can cause leg pain or swelling, but may occur without any symptoms … deep vein thrombosis is a serious condition because blood clots in your veins can break loose, travel through your bloodstream and lodge in your lungs, blocking blood flow (pulmonary embolism). (2) The Center for the Biology of Chronic Disease (CBCD) therefore recommends that individuals infected with CMV take Gene-Eden-VIR or Novirin against the latent form of the virus. The formula of these natural antiviral products was shown to reduce symptoms of CMV infection in two separate post-marketing clinical studies that followed FDA guidelines. Moreover, the formula was designed to help the immune system target the latent CMV.

Click to learn more about CMV symptoms.

The formula of Gene-Eden-VIR and Novirin was tested by Hanan Polansky and Edan Itzkovitz from the CBCD in two clinical studies that followed FDA guidelines. The studies showed that the Gene-Eden-VIR and Novirin formula is effective against the herpes family of viruses, including the human cytomegalovirus (CMV). The clinical studies were published in the peer reviewed, medical journal Pharmacology & Pharmacy, the first, in a special edition on Advances in Antiviral Drugs. Study authors wrote that, “individuals infected with the CMV … reported a safe decrease in their symptoms following treatment with Gene-Eden-VIR.” (3) The study authors also wrote that, “we observed a statistically significant decrease in the severity, duration, and frequency of symptoms.” (3)

Both products can be ordered online on the Novirin and Gene-Eden-VIR websites, here:

http://www.gene-eden-vir.com

and

http://www.novirin.com

Gene-Eden-VIR and Novirin are natural antiviral dietary supplements. Their formula contains five natural ingredients: Selenium, Camellia Sinesis Extract, Quercetin, Cinnamomum Extract, and Licorice Extract. The first ingredient is a trace element, and the other four are plant extracts. Each ingredient and its dose was chosen through a scientific approach. Scientists at polyDNA, the company that invented and patented the formula, scanned thousands of scientific and medical papers published in various medical and scientific journals, and identified the safest and most effective natural ingredients against latent viruses. To date, Novirin and Gene-Eden-VIR are the only natural antiviral products on the market with published clinical studies that support their claims.

Note: Novirin has the same formula as Gene-Eden-VIR. However, it contains higher quality and more expensive ingredients.

When CMV causes deep vein thrombosis, symptoms can include, “Swelling in the affected leg. Rarely, there may be swelling in both legs. Pain in your leg. The pain often starts in your calf and can feel like cramping or a soreness.” (2)

What treatments are available against the cytomegalovirus?

“Several drugs are approved for the treatment of CMV infections in immunocompromised individuals. These drugs include ganciclovir, its oral prodrug valganciclovir, cidofovir, foscavir and fomivirsen. However, the use of these drugs in immunocompetent individuals is limited by their toxicity, poor oral bioavailability, modest efficacy, and the development of drug resistance.” (3) There are also two natural CMV remedies with a clinically proven formula.

The CBCD reminds the public that Gene-Eden-VIR and Novirin are not a cure for conditions caused by CMV. However, two clinical studies showed that their formula decreases symptoms in infected individuals. Specifically, the formula of Gene-Eden-VIR and Novirin was designed to help the immune system target the latent virus.

The CBCD believes that these facts, combined with the medical evidence presented above, indicate the need to target latent viruses like CMV. “We recommend that infected individuals talk to their doctors about Gene-Eden-VIR or Novirin.” – Greg Bennett, CBCD

Find us on Facebook here: https://www.facebook.com/GeneEdenVIR
Follow us on Twitter here: @HananPolansky

All orders of Gene-Eden-VIR and Novirin are completely confidential, and no information is shared or sold to any third party. Privacy is assured.

References:

(1) Galli L1, Gerdes VE2, Guasti L3, Squizzato A3. "Thrombosis Associated with Viral Hepatitis." J Clin Transl Hepatol. 2014 Dec;2(4):234-9.

(2) MayoClinic.org - "Diseases and Conditions
Deep vein thrombosis (DVT)" Definition - Last updated July 3, 2014

(3) Polansky H, Itzkovitz E. Gene-Eden-VIR Is Antiviral: Results of a Post Marketing Clinical Study. Pharmacology & Pharmacy, 2013, 4, 1-8
http://www.scirp.org/journal/PaperInformation.aspx?PaperID=36101#.VCfZypSSz90

Greg Bennett
CBCD
585-250-9999
email us here

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.